New study aims to help MG patients reduce steroid use safely
NCT ID NCT07221838
First seen Nov 01, 2025 · Last updated May 16, 2026 · Updated 28 times
Summary
This study looks at whether people with generalized myasthenia gravis (gMG) who are already taking the drug ravulizumab can safely reduce or stop their oral steroids. About 75 adults will follow a step-by-step steroid-tapering schedule. The goal is to lower steroid doses without making their muscle weakness worse.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GENERALIZED MYASTHENIA GRAVIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Research Site
NOT_YET_RECRUITINGChicago, Illinois, 60637, United States
-
Research Site
NOT_YET_RECRUITINGSchaumburg, Illinois, 60173, United States
-
Research Site
NOT_YET_RECRUITINGNeptune City, New Jersey, 07753, United States
-
Research Site
RECRUITINGRaleigh, North Carolina, 27607, United States
-
Research Site
NOT_YET_RECRUITINGKnoxville, Tennessee, 37920, United States
-
Research Site
NOT_YET_RECRUITINGBochum, 44789, Germany
-
Research Site
NOT_YET_RECRUITINGMilan, 20122, Italy
-
Research Site
NOT_YET_RECRUITINGNaples, 80131, Italy
-
Research Site
NOT_YET_RECRUITINGRome, 00189, Italy
-
Research Site
NOT_YET_RECRUITINGIbaraki, 305-8576, Japan
-
Research Site
NOT_YET_RECRUITINGKitakyushu-shi, 807-8555, Japan
-
Research Site
NOT_YET_RECRUITINGKumamoto, 860-8556, Japan
Conditions
Explore the condition pages connected to this study.